Collplant Biotechnologies Ltd
NASDAQ:CLGN

Watchlist Manager
Collplant Biotechnologies Ltd Logo
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Watchlist
Price: 1.81 USD -4.74% Market Closed
Market Cap: 23m USD

Net Margin
Collplant Biotechnologies Ltd

-491.3%
Current
-1 643%
Average
-6.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-491.3%
=
Net Income
-12.2m
/
Revenue
2.5m

Net Margin Across Competitors

No Stocks Found

Collplant Biotechnologies Ltd
Glance View

Market Cap
23.1m USD
Industry
Biotechnology

CollPlant Biotechnologies Ltd. is a regenerative medicine company, which engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. The firm provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).

CLGN Intrinsic Value
7.75 USD
Undervaluation 77%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-491.3%
=
Net Income
-12.2m
/
Revenue
2.5m
What is the Net Margin of Collplant Biotechnologies Ltd?

Based on Collplant Biotechnologies Ltd's most recent financial statements, the company has Net Margin of -491.3%.

Back to Top